Site icon pharmaceutical daily

AmerisourceBergen Releases 2022 ESG Summary Report to Share Progress and Impact on Environmental, Social and Governance Priorities

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–AmerisourceBergen (AB), a global healthcare company, released its 2022 Environmental, Social and Governance (ESG) Summary Report. The report and ESG Reporting Index, which are both available through a microsite, contain detailed information on AB’s ESG performance and its commitment to fostering a positive impact on the planet and all people. For the fifth year in a row, selected material topics and indicators contained in the report and reporting index have been assured by ERM Certification and Verification Services.

“At AmerisourceBergen, we are dedicated to sustaining a healthy planet and improving human and animal health through innovation, strategic investments, critical partnerships, and corporate stewardship,” said Gina Clark, EVP and Chief Communications & Administration Officer at AmerisourceBergen. “As our global footprint continues to grow, so does our responsibility as global citizens. I’m proud of all that we have achieved as we continue to advance our ESG journey. We will continue to prioritize efforts and initiatives that protect and care for the health and wellbeing of our customers, team members, and the communities where we live and work.”

AmerisourceBergen is continuously focused on operating as a responsible business and advancing ESG initiatives to create healthier futures around the world. Most recently, AmerisourceBergen was included in the S&P Global Sustainability Yearbook – the world’s most comprehensive publication on corporate sustainability – as a result of the company’s high scores within its industry on S&P Global’s 2022 Corporate Sustainability Assessment.

AmerisourceBergen’s ESG strategy centers on three key priorities:

Purpose-Driven Team Members: Around the globe, AB engages team members and fosters a diverse and inclusive workforce in which our purpose is shared and individually celebrated. Highlights include:

Resilient and Sustainable Operations: AB is committed to efficient and responsible operations across its global supply chain, accelerating the delivery of medications and healthcare services while fostering diversity in the supplier base and partnerships to reduce environmental impact. Highlights include:

Healthy Communities for All: AB inspires equitable access to healthcare services within global communities and patient populations by striving to make programs and medication accessible where needed most. Highlights include:

For more information on the 2022 ESG Summary Report, please visit: https://esg.amerisourcebergen.com/.

In addition to external assurance and verification, the report has been prepared with reference to the Global Reporting Initiative (GRI) Universal Standards 2021. The ESG Reporting Index is aligned with the Sustainability Accounting Standards Board (SASB), Task Force on Climate-related Financial Disclosures (TCFD), World Economic Forum (WEF) Stakeholder Capitalism Metrics, and the United Nations Sustainable Development Goals (UNSDGs).

About AmerisourceBergen

AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.amerisourcebergen.com.

Contacts

Lauren Esposito

215-460-6981

lesposito@amerisourcebergen.com

Exit mobile version